Ping-Chien Lee(李秉謙), Ching-Chun Lin(林靜君), Hui-Hsuan Hsu(徐卉宣), Feng-Di T. Lung(龍鳳娣)* (2024.02). Antioxidant and Neuroproliferative Effects of THL-3-PTD5 Peptide Derived from Hydramacin-1 Antimicrobial Peptide. Journal of Chemistry, 2024, 8897847.
期刊論文
48筆資料 more...
Ping-Chien Lee(李秉謙), Chi-Fang Ye(顏頎方), Ching-Chun Lin(林靜君), Feng-Di T. Lung(龍鳳娣)* (2023.11). Designing the antimicrobial peptide with centrosymmetric and amphipathic characterizations for improving antimicrobial activity. Journal of Peptide Science, 29(11), e3510.
Chi-Sheng Cheng(程稚盛), Bor-Rung Ou(歐柏榮) andFeng-Di Lung(龍鳳娣)* (2022.04). Developing a Biosensor-Based Immunoassay to Detect HPV E6 Oncoprotein in the Saliva Rinse Fluid of Oral Cancer Patients. Journal of Personalized Medicine, 12, 594.
Ping‐Chien Lee(李秉謙), Chia‐Chun Chu(朱佳駿), Yi‐Je Tsai(蔡宜哲), Ya‐Chu Chuang(莊雅筑), Feng‐Di Lung (龍鳳娣)* (2019.07). Design, synthesis, and antimicrobial activities of novel functional peptides against Gram‐positive and Gram‐negative bacteria. Chemical Biology & Drug Design, 94, 1537-1544.
Yu-Cheng Hsiao , Ming-Hsuan Chang, John J. S. Chen , Chien-Chung Liou(劉建忠) , Feng-Di T. Lung(龍鳳娣)* (2014.06). Immunoaffinity Nanoprobe-Based MALDI-TOF MS for Detection of Fragments of N-Telopeptides of Type I Collagen. Int J of Pept Res and Ther, 20(2), 117-125.
Yu-Cheng Hsiao, Chen-Yu Lee, Yi-Jhen Lin, Shu-Huai Tsai, Kee-Ching G. Jeng, Wei-Ting Chao (趙偉廷), Feng-Di T. Lung* (龍鳳娣) (2013.11). Design, Synthesis, and Evaluation of Fluorescent Cell-penetrating Peptidic Antagonists of Grb2 SH2 for Targeting MCF-7 Breast Cancer Cells. Medicinal Chemistry Research, 22(11), 5337-5343.
Yu-Cheng Hsiao, De-Len Yang, Hui-Ling Hung and Feng-Di T. Lung(龍鳳娣)* (2013.10). Structure activity relationships of peptidic analogs of MyoD for the development of Id1 inhibitors as antiproliferative agents. Journal of Peptide Science, 19, 676-683.
Yu-Cheng Hsiao, Kai-Shiuan Wang, Shu-Huai Tsai, Wei-Ting Chao , Feng-Di T. Lung*(龍鳳娣)* (2013.08). Anticancer activities of an antimicrobial peptide derivative
of Ixosin-B amide. Bioorganic & Medicinal Chemistry Letters, 23, 5744-5747.
Yu-Shan Wu*, Zih-Jie Liao, Kai-Shiuan Wang, Feng-Di T. Lung (2013.04). Structure–activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide. Bioorganic & Medicinal Chemistry Letters, 23, 2929-2932.
Yu-Cheng Hsiao, Chen-Yu Lee , Yi-Jhen Lin ,Shu-Huai Tsai, Kee-Ching G. Jeng , Wei-Ting Chao(趙偉廷) ,and Feng-Di T. Lung(龍鳳娣)* (2013.02). Design, synthesis, and evaluation of fluorescent cell-penetrating
peptidic antagonists of Grb2-SH2 for targeting MCF-7
breast cancer cells. Medicinal Chemistry Research, 22, 5337-5343.
Feng-Di T. Lung, Kai-Shiuan Wang, Zih-Jie Liao, Sheng-Kai Hsu, Fei-Yi Song, Chien-Chung Liou,Yu-Shan Wu (2012.04). Discovery of potent antimicrobial peptide analogs of Ixosin-B. Bioorganic & Medicinal Chemistry Letters 22 (2012) 4185-4188, 22, 4185-4188.
Shih-Ying Yang, Yeh Chen, Chia-Xin Yang, De-Len Yang,
Sheng-Chu Kuo, Li-Jiau Huang and Feng-Di T. Lung（2011.10）。Structure Activity Relationships of a Peptidic Antagonist of Id1 Studied by Biosensor Method, Circular Dichroism Spectroscopy, and Bioassay。Journal of Peptide Science，17（10），667-674。
Chiu-Heng Chen, Sheng-Chu Kuo, Li-Jiau Huang, Mei-Hua Hsub, Feng-Di T. Lung (2010.05). Affinity of synthetic peptide fragments of MyoD for Id1 protein and their biological effects in several cancer cells. Journal of Peptide Science, 16(5), 231-241.
Chiu-Heng Chen, Meng-Kai Chen, Kee-Ching G. Jeng, Feng-Di T. Lung (2010.01). Effects of Peptidic Antagonists of Grb2-SH2 on Human Breast Cancer Cells. Protein & Peptide Letters, 17(1), 44-53.
Feng-Di T Lung(龍鳳娣)*, Wan-Ching Li, Yung-Hsien Chang, Hui-Ming Chen (2008.04). Determination of binding potency of peptidic inhibitors of Grb2-SH2 by using the protein-captured biosensor method. Protein & Peptide Letters, 15(8), 806-810.
Lung Feng-Di;Chang Chiung-Wen;Chong Meng-Chin;Liou Chien-Chung;Li Peng;Peach Megan L;Nicklaus Marc C; Lou Bih-Show;Roller Peter P. (2005.01). Small nonphosphorylated Grb2-SH2 domain antagonists evaluated by surface plasmon resonance technology.. Biopolymers (Peptide Science), 80(5), 628-635.
Lung* F-D T, Chang C-W, Chong M-C, Liou C-C, Li P, Peach M L , Nicklaus M, Roller P.P and Tsai JY. (2005.01). Small Non-Phosphorylated Grb2 SH2 Domain Antagonists Evaluated by SPR Technology.. Biopolymer Peptide Science, , 628-635.
Chen H-P, Lung F-D T, Yeh C-C, Chen H-L and Wu S-H. (2004.10). The role of the Conserved Histidine-Aspartate Pair in the ‘Base-off’ Binding of Cobalamins.. Bioorganic & Medicinal Chemistry, 12, 577-582.
Lung* F-D T, Chen C-H, Liou C-C and Chen H-Y. (2004.05). Surface Plasmon Resonance Detection of Interactions Between Peptide Fragments of N-telopeptide and its Monoclonal Antibodies.. The Journal of Peptide Research, 63, 365-370.
Lung* F-D T and Tsai J-Y. (2003.08). Grb2 SH2 Domain-Binding Peptide Analogs as Potential Anticancer Agents.. Biopolymer (Peptide Science), 71, 132-140.
Long Y-Q, Lung F-D T and Roller P.P. (2003.06). Global Optimization of Conformational Constraint on Non-phosphorylated Cyclic Peptide Antagonists of the Grb2-SH2 Domain.. Bioorganic and Medicinal Chemistry, 11, 3929-3936.
Lung* F-D T, Chen H-Y and Lin H-Z. (2003.04). Monitoring Bone Loss Using ELISA and surface Plasmon resonance (SPR) technology.. Protein and Peptide Letters, 10(3), 313-319.
Lung F-D T＊, Tsai JY, Wei SY, Cheng JW, Chen C, Li P, and Roller PP (2002.10). Novel peptide inhibitors for Grb2 SH2 domain and their detection by Surface Plasmon Resonance.. The Journal of Peptide Research, , 143-149.
Lung F-D T. Chen C-H, Chen H-Y, Liou, C-C and Liou Y-M. (2002.08). Binding Potency of Peptide Fragments of type I Collagen Cross-linked N-Telopeptide measured by an enzyme-linked immunosorbant assay.. Protein and Peptide Letters, 9(5), 451-457.
Tsai JY, and Lung F-D T＊ (2002.06). Manual solid phase synthesis of potent peptide analogs.. The Chinese Pharmaceutical Journal, 54, 141-147.
Chen HM, Huang LJ, Chang TH, Chen HY, Lung F-D T*, and Kuo SC. (2001.08). Application of BIA Technology in Screening Potential MAT Inhibitors.. The Chinese Pharmaceutical Journal, 53, 147-155.
Chen HM, Hsu MS, Huang LJ, Chung JG, Chen HY, Lung F-D T, Lung, Hung CF, Liau MC, and Kuo SC. (2001.07). Effect of N-Phenylacetyl L-Amino Acids on the Differentiation of HL-60 Cells.. The Chinese Pharmaceutical Journal, 53, 157-167.
Kovalsky O, Lung F-D T, Roller PP, and Fornace, Jr. AJ (2001.06). Oligomerization of Human Gadd45a Protein.. The Joural of Biological Chemistry, 276(42), 39330-39339.
Lung F-D T, Long Y-Q, King C R, Varady J, Wu X-W, Wang S, Roller PP. (2001.05). Functional preference of the constituent amino acid residues in a phage-library-based nonphosphorylated inhibitor of the Grb2-SH2 Domin.. Journal of Peptide Research, 57, 447-454.
Tzeng SR, Pai MT, Lung F-D T, Wu C-W, Roller PP, Lei B, Wei C-J, Tu S-C, Chen S-H, Soong WJ, and Cheng J-W. (2000.10). Stability and Peptide Binding Specificity of Btk SH2 Domain: Molecular Basis for X-linked Agammaglobulinemia.. Protein Science, 9, 2377-2385.
Tu YS, Huang L, Hsu M-H, Wang S-H, Lai J-M, Yeh CC, Liau M-C, Lung F-D T*., Kuo S-C. (2000.06). Synthesis of Hemoregulatory Peptide（HP）Derivatives as Lnhibitors of the Interaction between Methionine Adenosyl Transferase and Methionine.. The Chinese Pharmaceutical Journal, 52, 139-149.
Jin S, Antinore M, Lung F-D T, Dong X, Zhao H, Fan F, Colchaie AB, Blanck P, Roller PP, Fornance AJ, and Zhan Q (2000.05). The GADD45 Inhibition of Cdc2 Kinase Correlates with GADD45-mediated Growth Suppression.. The Journal of Biological Chemistry, 275, 16602-16608.
Lou YC, Lung＊F-D T, Pai MT, Tzeng SR, Wei SY, Roller PP, and Cheng JW. (1999.12). Solution Structure and Dynamics of a Nonphosphorylated Cyclic Peptide Inhibitor for Grb2 SH2 Domain.. Archives of Biochemistry and Biophysic, 372(2), 309-314.
Lung F-D T, King CR, and Roller PP. (1999.10). Development of non-phosphorylated cyclic thioether peptide binding to Grb2-SH2 domain. Letters in Peptide Science, 6, 45-49.
Long YQ, Yao ZJ, Voigt JH, Lung F-D T, Luo JH, Burke TR Jr., King CR, Yang D, and Roller PP (1999.09). Structural Requirements for Tyr in the Consensus Sequence Y-E-N of a Novel Nonphosphorylated Inhibitor to the Grb2-SH2 Domain. Biochemical and Biophysical Research Communications, 264(3), 902-908.
Mutoh M, Lung F-D T, Long YQ, Roller PP, Robert SS, and O'Connor PM. (1999.07). A p21Waf1/Cip1 Carboxy-terminal Peptide Exhibited Cyclin-dependent Kinase-inhibitory Activity and Cytotoxicity When Introduced into Human Cells.. Cancer Research, 59, 3480-3488.
Long YQ, Voigt JH, Lung F-D T, King CR, and Roller PP. (1999.07). Significant Compensatory Role of Position Y-2 Conferring High Affinity to Non-Phosphorylated Inhibitors of Grb2-SH2 Domain.. Bioorganic and Medicinal Chemistry Letters, 9, 2267-2272.
Chittum H S, Lane W S, Carlson B A, Roller P P, Lung F-D T, Lee B J,and Hatfield D L (1998.06). Rabbit ？-Globin Is Extended Beyond Its UGA Stop Codon by Multiple Suppressions and Translational Reading Gaps.. Biochemistry, 37(31), 10866-10870.
Oligino L,Lung F-D ,Sastryi L,Bigelow J,Cao T,Curran M,Burke,T R,Wang S,Krag D,Roller P P, and C. Richter King C R. (1997.07). Nonphosphorylated Peptide Ligands for the Grb2 Src Homology 2 Domain.. The Journal of Biological Chemistry, 272(46), 29046-29052.
Huang X, Barchi, J J, Lung F-D T, Roller P P, Nara P L, Muschik j, and Garrity R R (1997.06). Glycosylation Affects both the Three-Dimensional Structure and Antibody BindingProperties of the HIV-1IIIB GP120 Peptide RP135.. Biochemistry, 36(36), 10846-10856.
Chen T. Akamatsu M. Smith ML. Lung F-D T. Duba D. Roller PP. Fornace AJ Jr and O’Connor PM. (1996.12). Characterization of p21Cp1/Waf1 Peptide Domains Required for Cyclin E/Cdk2 and PCNA Interaction .. Oncogene, 12, 595-607.
Lung F-D,Meyer J-P,Lou B-S,Xiang L,Li G,Davis P,De Leon I A, Yamamura H I,Porreca F,and Hruby V J. (1996.09). Effects of Modifications of Residues in Position 3 of Dynorphin A(1-11)-NH2 on K Receptor Selectivity and Potency.. Journal of Medicinal Chemistry,, 39(13), 2456-2460.
Lung F-D T, Collins N, Davis P, Yamamura H I, Porreca F, Hruby V J. (1996.05). Design, Synthesis, and Biological Activities of Cyclic Lactam Peptide Analogues of Dynorphin A(1-11)-NH2.. Journal of Medicinal Chemistry, 39(5), 1136-1141.
Lung F-D T, Meyer JP, Li G, Lou BS Stropova D, Davis P, Yamamura HI, Porreca F, and Hruby VJ. (1995.10). Highly k Receptor-Selective Dynorphin A Analogues with Modifications in Position 3 of Dynorphin A(1-11)-NH2.. Journal of Medicinal Chemistry, 38(4), 585-586.
Lung F-D, Li G, Lou BS, and Hruby VJ. (1995.10). A New Strategy for the Synthesis of Four Individual Isomers of Methylphenylalanine.. Synthetic Commyunications, 25(1), 57-61.
Lou BS, Li G, Lung F-D, and Hruby VJ. (1995.07). The Direct NMR Investigation of Asymmetric Michael-like Addition Reaction and Electrophilic Reaction.. Journal of organic Chemistry, 60, 5509-5514.
Hruby NJ, Collins N, Lung F-D, Meyer JP, Davis TP, Yamamura HI, and Porreca F. (1995.06). Design of Peptides and Peptidomimetics for Delta and Kappa Opioid Receptor Subtypes.. Regulatory Peptides, 54, 123-124.
Meyer JP, Collins N, Lung F-D, Davis P, Zalewaska T, Porecca F. Yamamura HI and Hruby VJ. (1994.04). Design, Synthesis and Biological Properties of Highly Potent Cyclic Dynorphin Analogues. Analogues Cyclized Between Positions 5 and 11.. Journal of Medicinal Chemistry, 37(23), 3910-3917.
研討會論文
47筆資料 more...
Chun-Huai Rau, Cheng-Hsien Tsai, Yu-Tsung Lin, Feng-Di Lung* (2023.11). Antimicrobial Activity Assay of MH 2 Series Peptides. Paper presented at 2023先進化學學用合一研討會暨學生論文發表會, 靜宜大學靜安樓101會議廳: 靜宜大學應用化學系.
Yu-Yu Liu, Yung-En Shen, Yi-Tung Cheng, Feng-Di Lung (2023.11). Antimicrobial Peptide MAP-04-03 Modification and Synthesis Based on the Structure-Activity Relationship Obtained by Alanine Scanning. Paper presented at 2023先進化學學用合一研討會暨學生論文發表會, 靜宜大學靜安樓101會議廳: 靜宜大學應用化學系.
Ching-Chun Lin, Mey-Fann Lee2, Yu-Wen Chu, Feng-Di Lung* (2023.07). Investigation of Anti-atopic Dermatitis Effects of
Synthetic Peptides by in vitro Cell Model (III). Paper presented at 臺中榮民總醫院與中區各大學合作研究計畫成果發表會, 臺中榮民總醫院研究大樓1樓第二會場及走廊: 臺中榮民總醫院.
Kuan-Hung Chen, Yi-Cih Lai, Yung-En Shen, Yi-Tung Cheng, Shiuan-Ru Chen, Feng-Di Lung(龍鳳娣) * (2023.03). Design and synthesis of MH2-3 peptide derivatives and the investigation of their antibacterial and anti-breast cancer activities. Paper presented at 2023化學年會 化學新紀元-永續發展, 國立高雄大學理學院及圖書資訊大樓: 國立高雄大學.
Shiuan-Ru Chen, Chen-Yao Chen, Yu-Tsung Lin, Chun-Huai Rau, Ching-Chun Lin, Feng-Di Lung(龍鳳娣)* (2023.03). Structure-activity Relationships of Antimicrobial Peptide MAP-04-03 Studied by Alanine Scan Approach. Paper presented at 2023化學年會 化學新紀元─永續發展, 國立高雄大學理學院及圖書資訊大樓: 國立高雄大學.
Yi-Tung Cheng, Yung-En Shen, Kuan-Hung Chen, Yi-Cih Lai, Cheng-Hsien Tsai, Feng-Di Lung(龍鳳娣)* (2023.03). Alanine Scanning and Anti-Breast Cancer Activity of Antimicrobial Peptide MAP-04-03. Paper presented at 2023化學年會 化學新紀元一永續發展, 國立高雄大學理學院及圖書資訊大樓: 國立高雄大學.
Yung-En Shen, Chin-Lin Chang, Huai-Hsin He, Feng-Di, Lung(龍鳳娣)* (2022.11). Evaluation of Antibacterial and Anti-Breast Cancer Activity of Peptides SH-01 and SH-02. Paper presented at 2022先進化學學用合一研討會暨學生論文發表會, 靜宜大學: 靜宜大學應用化學系.
Chi-Fang Yen, Wan-Hua Liu, ping-Chien Lee, Feng-Di Lung(龍鳳娣) (2022.11). DesignandCharacterization of Perfect Amphipathica-helical Antimicrobial Peptides. Paper presented at 2022先進化學學用合一研討會暨學生論文發表會, 靜宜大學: :靜宜大學應用化學系.
Ching-Chun Lin, Mey-Fann Lee, Yu-Wen Chu, Feng-Di Lung* (2022.10). Investigation of Anti-atopic Dermatitis Effects of Synthetic Peptides by in vitro Cell Model (II). Paper presented at 臺中榮民總醫院與中區各大學合作研究計畫成果發表會, 臺中榮民總醫院研究大樓2樓走廊: 臺中榮民總醫院.
Ping-Chien Lee(李秉謙), Ching-Chun Lin(林靜君), Feng-Di T. Lung(龍鳳娣)* (2018.12). Antioxidant and Neuroproliferative Activities of Peptidic Analogs of Hydramacin-1. Paper presented at 10th International Peptide Symposium (10th IPS), Kyoto, Japan: Japanese Peptide Society.
Ping-Chien Lee(李秉謙), Ching-Chun Lin(林靜君), Hui-Hsuan Hsu(徐卉宣), Feng-Di, Lung(龍鳳娣)* (2018.12). Structure-Activity Relationships Studies of Ala-substituted Analogs of A Potent Antioxidant Peptide THL-3. Paper presented at 2018中國化學年會, 中山大學, 高雄, 台灣: 中國化學會.
Y. Tsai, C. Cheng, G. Chen, C. Chu, D. Yang, B. Ou(歐柏榮), F. Lung(龍鳳娣)* (2017.08). Development of Biosensor-based Methods for Detecting Disease Biomarkers in Saliva of Patients with Oral Cancer. Paper presented at 2017 INTERNATIONAL SYMPOSIUM FOR ADVANCED MATERIALS RESEARCH (ISAMR 2017), 南投縣魚池鄉日月潭-教師會館: Asia Pacific Society for Materials Research.
Ping-Chien Lee(李秉謙), Chia-Chun Chu(朱佳駿), Yi-Je Tsai(蔡宜哲), Feng-Di Lung(龍鳳娣)* (2017.08). A Novel Antimicrobial Peptide Discovered by Structure-Activity Relationships Studies of Ixosin-B. Paper presented at 2017 INTERNATIONAL SYMPOSIUM FOR ADVANCED MATERIALS RESEARCH (ISAMR 2017), 南投縣魚池鄉日月潭-教師會館: Asia Pacific Society for Materials Research.
Yi-Je Tsai(蔡宜哲), Chi-Shang Cheng(程稚盛), Shen-Rong Su(蘇信榮), Huai-Hsin He(何懷忻), Ya-Jou Chang(張雅柔), De-Lun Yang(楊德倫), Chia-Chun Chu(朱佳駿), Bor-Rung Ou(歐柏榮), Feng-Di Lung(龍鳳娣)* (2016.12). Development ofimmunoassay and biosensor methods for detection of biomarkers in saliva of patients with oral cancer. Paper presented at 2016中國化學年會, 中興大學惠蓀堂: 中興大學化學系.
De-Lun Yang(楊德倫), Jen-Yi Wu(吳俊毅), Chih-Hui Wang(王智慧), Feng-Di Lung(龍鳳娣)* (2016.12). Synthesis and Antimicrobial Activities of Peptidic Analogs of MyoD.. Paper presented at 2016中國化學年會, 中興大學惠蓀堂: 中興大學化學系.
Chan-Ru Chan(詹湛如), De-Lun Yang(楊德倫), Chia-Chun Chu(朱佳駿), Guan-Ting Chen(陳冠婷), Feng-Di Lung(龍鳳娣)* (2016.12). Synthesis and Bioactivities Studies of Peptidic Inhibitors of MAPK for the Development of Anticancer Agents. Paper presented at 2016中國化學年會, 中興大學惠蓀堂: 中興大學化學系.
De-Lun Yang(楊德倫), Jen-Yi Wu(吳俊毅), Chih-Hui Wang(王智慧), Fung-Di Lung(龍鳳娣)* (2016.05). Synthesis and Antimicrobial Activities of Synthetic Peptidic Analogs of MyoD. Paper presented at 2016先進化學學用合一研討會, 靜宜大學理學院靜安101: 靜宜大學應用化學系，中國化學會台中分會.
C.C. Chu(朱佳駿), Y.C. Chuang(莊雅筑), Y.J. Tsai(蔡宜哲), F.D. Lung(龍鳳娣) * (2015.12). Structure-Activity Relationships Studies of Potent Antimicrobial Peptides. Paper presented at 2015年中國化學年會, 花蓮縣壽豐鄉大學路2段1號 理工一館: 國立東華大學化學系.
Chi-Shang Cheng(程稚盛), De-Len Yang(楊德倫), Chia-Chun Chu(朱佳駿), Shen-Rong Su(蘇信榮), Feng-Di Lung(龍鳳娣)* (2015.12). Preparation of Immunomagnetic Nanoparticles and Development of Biomedical Methods for Detection of Oral Cancer. Paper presented at 2015年中國化學年會, 花蓮縣壽豐鄉大學路2段1號 理工一館: 國立東華大學化學系.
Z.S. Cheng (程稚盛), X. R. Su (蘇信榮), M. Y. Ni (倪孟元), P. H. Lin (林品豪), Y. X. Yang (楊雨軒), F. D. Lung* (龍鳳娣) (2015.07). Biostability of proteins in saliva studied by BCA protein assay. Paper presented at 第十二屆台灣質譜學會年會暨學術研討會, 國立交通大學 基礎科學教學研究大樓: 國立交通大學應用化學系.
J. J. Zhu (朱佳駿), T. Y. Shen (沈子矞), Y. C. Chuang (莊雅筑), Y. J. Tsai (蔡宜哲), Z. R. Zhan (詹湛如), F. D. Lung* (龍鳳娣) (2015.07). Design, Synthesis, and Antimicrobial Activity of a Potent Peptide Analog. Paper presented at 第十二屆台灣質譜學會年會暨學術研討會, 國立交通大學 基礎科學教學研究大樓: 國立交通大學應用化學系.
D.L. Yang(楊德倫), T.Y. Shen(沈子矞), J.J. Jhu(朱佳駿), C.I Wu(吳俊毅), C.H.Wang(王智慧), F.D. Lung(龍鳳娣) (2014.11). Development of anti-cancer agent based on the peptide fragment in the N-terminal of helix 2 motif of MyoD protein. Paper presented at 中國化學會, 工研院中興院區51館一樓: 交通大學與工業技術研究院.
Chih-Wei Chuang (莊志唯), Shiang-Jiun Lin (林香君), Yu-Ching Chen (陳育卿), Chi-Shang Cheng (程稚盛), Bor-Rung Ou (歐柏榮), Wei-Je Lin (林維哲), Man-Yee Chan (陳萬宜)*, Feng-Di Lung (龍鳳娣)* (2014.06). Preparation of Immunomagnetic Nanoparticles and Development of Biomedical Methods for Detecetion of Oral Cancer. Paper presented at 102年度臺中榮民總醫院與中區各大學合作研究計畫成果發表會, 臺中榮總研究大樓二樓: 臺中榮民總醫院.
Chun-Guang Cai(蔡淳光), Tzu-Yu Shen(沈子矞), Jainming Zheng(鄭建明), Feng-Di T.Lung*(龍鳳娣) (2013.11). Synthesis and Bioassays of Potent N-methylated Antimicrobial Peptides. Paper presented at 中國化學年會, 暨南大學: 暨南大學.
Po-Tsung Liao (廖柏宗), Fang-Yin Kuo (郭芳吟), Chun-Guang Cai (蔡淳光), Feng-Di Lung (龍鳳娣) (2012.12). Design, Synthesis and Antimicrobial Activity of Peptidic Analogs of Ixosin-B amide. Paper presented at 中國化學會, 成功大學中正堂: 成功大學.
Lei-Way Huang(黃笠崴),Hsien-Fu Tseng(曾憲夫),Huei-Yu Liou(劉蕙瑜),Ying-Fong Hsu(許瀛丰),Feng-Di Lung(龍鳳娣) (2012.06). Development of an efficient method for monitoring the progression of oral cancer by using MALDI-TOF MS. Paper presented at 華人質譜年會, 成功大學: 成功大學.
Lei-Way Huang(黃笠崴),Hsien-Fu Tseng(曾憲夫),Huei-Yu Liou(劉蕙瑜),Ying-Fong Hsu(許瀛丰),Feng-Di Lung(龍鳳娣) (2011.12). Discovery of a biomarker in oral cancer tissues and cell lines by using MALDI-TOF MS. Paper presented at 中國化學會, 清華大學體育館: 清華大學.
De-Len Yang(楊德倫), Cha-Mei Lin(林佳玫), Pen-Yuan Liao(廖本原), Feng-Di Lung(龍鳳娣) (2011.12). Design, synthesis, and evaluation of effects of peptides on recognition and degradation of Id1 protein. Paper presented at 中國化學會, 清華大學體育館: 清華大學.
Kai-Shiuan Wang (王凱宣), Zih-Jie Liao (廖梓捷), Sheng-Kai Hsu (徐聖凱), Song Fei-Yi (宋飛儀)Chien-Chung Liou (劉建忠), Yu-Shan Wu (吳雨珊), Feng-Di Lung (龍鳳娣)（2010.12）。Design, Synthesis and Assay of Ixosin-B for the Development of Antimicrobial Peptides。論文發表於中國化學會，台灣大學綜合體育館：台灣大學。
Hui-Ling Hung (洪惠玲), Shih-Ying Yang (楊詩瑩), Chiu-Heng Chen (陳丘泓), Chia-Sin Yang (楊佳昕),Li-Jiau Huang (黃麗嬌), Yeah Chen (陳曄), Feng-Di Lung (龍鳳娣)（2010.12）。Synthesis of Peptides and Structure –Anticancer activity Relationships Studied by Surface Plasmon Resonance Technology, Circular Dichroism Spectroscopy and Bioassays。論文發表於中國化學會，台灣大學綜合體育館：台灣大學。
Ming-Hsuan Chang (張銘軒), Wan-Ching Lin (林宛靜), Ming-Yueh Hsien (謝明月) , Kee-Ching G. Jeng (鄭啟清), Chien-Chou Pan (潘建州), Jung-Shou Chen (陳榮壽), Feng-Di Lung (龍鳳娣)（2010.12）。Integration of Immunoaffinity Magnetic Nanoparticles with Mass Spectrometry for the Development of Methods for Monitoring Bone Loss。論文發表於中國化學會，台灣大學綜合體育館：台灣大學。
Chih-Wei Liao, Shih-Ying Yang, Feng-Di Lung,Chien-Wei Hou,Yuan-Fong Feng（2009.12）。Preparation, Characterization, and the in vitro and in vivo Bioassays of Pearl Peptides。論文發表於中國化學會，高雄：義守大學生物科技學系。
Chiu-Heng Chen, De-Len Yang, Chia-Sin Yang, Sheng-Chu Kuo, Li-Jiau Huang, Feng-Di Lung（2009.12）。SAR of MyoD peptide analogs studied by CD, SPR, and bioassays。論文發表於中國化學會，高雄：義守大學生物科技學系。
Chiu-Heng Chen, Yu-Cheng Hsiao, Tzu-Ying Lin, Kee-Ching G. Jeng, Hwei-Ming Wang, Feng-Di T. Lung（2009.05）。Development of Id 1-binding Peptide Analogs as Potential Anticancer Agents。論文發表於台中榮總與中區各大院校聯合成果發表會，台中榮民總醫院：台中榮民總醫院。
Chen C-H, Hsiao Y-C, Jeng K-C G. , Lung F-D T.（2009.03）。Development of Id1 Helix Domain-binding Peptide Analogs as Potential Anticancer Agents。論文發表於生物醫學聯合學術年會，國防醫學大學：中華民國細胞及分子生物學學會
台灣生物化學及分子生物學學會。
Lin T-Y, Yang C-Y, Ke C-Y, Lung F-D T（2008.12）。Effects of farnesyl transferase peptide inhibitors on breast cancer cells。論文發表於中國化學會，彰化：國立彰化師範大學。
Wu J-W, Yang S-Y, .Lung F-D T（2008.12）。Application of MALDI-TOF-MS for monitoring osteoporosis by using a peptide fragment of type I collagen crosslinked N-telopeptides (NTx) and its rabbit polyclonal antibody。論文發表於中國化學會，彰化：國立彰化師範大學。
Yu-Cheng Hsiao (蕭又誠), Li-Wen Su (蘇俐文), Kee-Ching G. Jeng (鄭啟清), Feng-Di T. Lung (龍鳳娣)（2008.06）。The studies of binding affinities and cell viabilities of Id inhibitors for Id protein。論文發表於台中榮民總醫院與中區各大院校聯合成果發表會，台中榮民總醫院：台中榮民總醫院。
Meng-Kai Chen (陳盟凱), Chen-Yu Lee (李振宇), Chiu-Heng Chen (陳丘泓), Kee-Ching G. Jeng(鄭啟清), Feng-Di T. Lung (龍鳳娣)（2007.03）。EFFECT OF STUDIES OF SYNTHETIC PEPTIDE INHIBITORS OF GRB2 SH2 IN HUMAN BREAST CANCER CELLS。論文發表於生物醫學聯合學術年會，國防醫學大學：中華民國細胞及分子生物學學會
台灣生物化學及分子生物學學會。
Yu-Cheng Hsiao (蕭又誠), Yun-Chan Ting (丁雲川), Feng-Di T. Lung (龍鳳娣)（2006.11）。Synthesis of Cyclic Peptide Fragments of Type I Collagen Cross-linked N-telopeptide for Developing Biomedical Method for Monitoring Bone Loss。論文發表於中國化學會(2006)，台北縣：淡江大學。
Meng-Kai Chen (陳盟凱), Chen-Yu Lee (李振宇), Feng-Di T. Lung (龍鳳娣)（2006.11）。Biological Activity Studies of Synthetic Peptide Inhibitors of Grb2 SH2 in Human Breast Cancer Cells。論文發表於中國化學會(2006)，台北縣：淡江大學。
Chiu-Heng Chen (陳丘泓), Fei-Yi Sung (宋飛儀), Meng-Kai Chen (陳盟凱), Feng-Di T. Lung (龍鳳娣)（2005.11）。DEVELOPMENT OF GRB2 SH2 DOMAIN INHIBITORS AS ANTI-CANCER AGENTS USING SYNTHETIC PEPTIDES AND BIOSENSOR TECHNOLOGY。論文發表於中國化學會(2005)，高雄：中山大學。
Guo S-C, Chong M-C, Yang H-W, Chiu H-W, Chou S-C, Ip S-W, Lung* F-D T.（2003.12）。Quantification of isoflavones in natural foods and Chinese herbal medicine by high performance liquid chromatography.(口頭論文)。論文發表於台灣食品科技學會第三十三次年會，嘉南藥理科技大學, 台南.：台灣食品科技學會。
Chong M-C, Guo S-C, Chen M-K, Chung P-H, Chung J-G, Lung* F-D T（2003.12）。The inhibitory effect of soybean milk on the growth of breast cancer cell lines。論文發表於台灣食品科技學會第三十三次年會，台南：嘉南藥理科技大學。
Lung* F-D T（2003.03）。Potent Grb2 SH2 domain inhibitor studied by surface plasmon resonance and biological assays。論文發表於台灣生物化學及分子生物學研討會，台大醫學院：台灣生物化學及分子生物學學會。
Lung* F-D T，（2003.02）。定量維生素 D3 之酵素連結免疫吸附分析法(ELISA)。論文發表於台灣保健食品研討會，台灣大學第二演講聽：台灣保健食品學會。
Lung* F-D T（2003.01）。Surface Plasmon Resonance Detection of Interactions between Peptide Fragments of N-Telopeptide and Its Monoclonal Antibodies。論文發表於中華民國細胞分子生物新知研討會，墾丁攸活飯店：中華民國細胞分子生物學會。
專利
7筆資料 more...
Feng-Di Lung (龍鳳娣)* (2019.03-2035.11). Novel peptide and uses thereof. United States Patent No: US10100086B2.
Feng-Di Lung (龍鳳娣)* (2019.03-2035.11). Peptide and uses thereof. United States Patent No: US9802982B2.
龍鳳娣、歐柏榮、顧野松、程稚盛、陳萬宜（2018.06-2037.10）。新穎胜肽、其抗體及以其評估口腔癌風險之方法。中華民國專利號碼：I627184。
龍鳳娣 (2016.06-2035.10). 新穎胜肽及其抗菌用途. 中華民國 Patent No: I538920.
龍鳳娣（2016.02-2034.11）。新穎抗菌胜肽及其用途。中華民國專利號碼：I522110。
龍鳳娣、陳明德、洪永豐、馮源風、丁云川（2011.07-2028.09）。奈米珍珠有機基質萃取與分子量純化的方法。中華民國專利號碼：I345477。
龍鳳娣、陳明德、洪永豐、馮源風、丁云川（2011.06-2031.06）。奈米珍珠有機基質萃取與分子量分級的方法。中華人民共和國專利號碼：ZL200810169588.8。